Atlas Trials

Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection

Clinical trial NCT03479294 · TERMINATED

Trial details

NCT number
NCT03479294
Sponsor
West China Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell LungChemotherapy, Adjuvant
Start date
2018-03-28
Primary completion
2018-09-10
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.